Adjudicación del Contrato Basado del Acuerdo Marco del Suministro de MEDICAMENTOS PARA EL TRATAMIENTO DE LA HIPERCOLESTEROLEMIA PRIMARIA (FAMILIAR HETEROZIGÓTICA Y NO FAMILIAR) O DISLIPEMIA MIXTA CON INHIBIDORES DE PCSK9, del Consorci Sanitari Integral
TED · 377925-2026Award noticeNo deadline given
Value
Estimated€319,770 · 319,770 EUR
Awarded—
Who already wins at this buyer
Firms with recorded awards from Consorci Sanitari Integral in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Laboratorios LEO Pharma, S.A. | 2 | €787,247 | 2026-05-07 |
| ROCHE DIAGNOSTICS, S.L.U. | 1 | €2,082,222 | 2026-07-21 |
| UCB PHARMA, S.A. | 1 | €1,887,515 | 2026-06-05 |
| BIOCON BIOLOGICS SPAIN | 1 | €528,490 | 2026-07-10 |
| Abast Medica S.L. | 1 | €409,179 | 2026-06-30 |
Full buyer profile: what Consorci Sanitari Integral buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
Adjudicación del Contrato Basado del Consorci Sanitari Integral derivado del Acuerdo Marco del Suministro de MEDICAMENTOS PARA EL TRATAMIENTO DE LA HIPERCOLESTEROLEMIA PRIMARIA (FAMILIAR HETEROZIGÓTICA Y NO FAMILIAR) O DISLIPEMIA MIXTA CON INHIBIDORES DE PCSK9, tramitado por el Consorci de Salut i d’Atenció Social de Catalunya
Similar tenders
Closest by meaning — across languages, via embeddings.